Development Level

Tbio 8 | 10,625
Tdark 3 | 7,003

IMPC Term

increased NK T cell number 11 | 11
preweaning lethality, complete... 633 | 633
preweaning lethality, incomple... 260 | 260
abnormal behavior 226 | 226
decreased lean body mass 195 | 195
embryonic lethality prior to t... 187 | 187
decreased total body fat amoun... 186 | 186
decreased body weight 174 | 174
decreased bone mineral content 157 | 157
embryonic lethality prior to o... 148 | 148
abnormal bone structure 131 | 131
increased or absent threshold ... 128 | 128
decreased bone mineral density 126 | 126
decreased grip strength 123 | 123
decreased circulating glucose ... 121 | 121
increased circulating alkaline... 119 | 119
abnormal embryo size 112 | 112
enlarged heart 111 | 111
decreased body length 108 | 108
hyperactivity 108 | 108
increased lean body mass 107 | 107
abnormal retina morphology 100 | 100
increased mean corpuscular hem... 93 | 93
increased bone mineral content 92 | 92
increased mean corpuscular vol... 91 | 91
hypoactivity 89 | 89
decreased circulating choleste... 85 | 85
decreased circulating triglyce... 83 | 83
increased grip strength 83 | 83
short tibia 82 | 82
decreased circulating serum al... 79 | 79
decreased circulating HDL chol... 77 | 77
decreased circulating insulin ... 75 | 75
abnormal lens morphology 73 | 73
increased circulating sodium l... 71 | 71
increased fasted circulating g... 68 | 68
prenatal lethality prior to he... 64 | 64
abnormal sleep behavior 63 | 63
increased circulating HDL chol... 63 | 63
decreased lumbar vertebrae num... 62 | 62
increased sacral vertebrae num... 62 | 62
male infertility 62 | 62
abnormal retinal pigmentation 61 | 61
decreased rib number 59 | 59
increased total body fat amoun... 57 | 57
improved glucose tolerance 56 | 56
increased exploration in new e... 56 | 56
abnormal bone mineralization 55 | 55
abnormal coat/hair pigmentatio... 54 | 54
decreased leukocyte cell numbe... 54 | 54
decreased circulating alanine ... 53 | 53
decreased hemoglobin content 53 | 53
increased circulating choleste... 53 | 53
abnormal behavioral response t... 52 | 52
decreased prepulse inhibition 52 | 52
impaired glucose tolerance 52 | 52
increased bone mineral density 52 | 52
abnormal gait 51 | 51
abnormal heart morphology 51 | 51
decreased mean corpuscular vol... 50 | 50
decreased caudal vertebrae num... 49 | 49
decreased fasted circulating g... 49 | 49
decreased startle reflex 48 | 48
abnormal seminal vesicle morph... 47 | 47
thrombocytopenia 46 | 46
increased hemoglobin content 45 | 45
decreased heart weight 44 | 44
increased blood urea nitrogen ... 44 | 44
decreased erythrocyte cell num... 43 | 43
increased circulating chloride... 43 | 43
increased body weight 42 | 42
decreased circulating alkaline... 41 | 41
decreased circulating total pr... 41 | 41
decreased eosinophil cell numb... 41 | 41
increased rib number 41 | 41
decreased circulating free fat... 39 | 39
abnormal eye morphology 38 | 38
increased startle reflex 38 | 38
abnormal neural tube closure 37 | 37
decreased circulating LDL chol... 37 | 37
decreased neutrophil cell numb... 37 | 37
increased heart weight 37 | 37
increased leukocyte cell numbe... 37 | 37
small testis 37 | 37
abnormal spleen morphology 36 | 36
increased hematocrit 36 | 36
cardiovascular system phenotyp... 35 | 35
limb grasping 35 | 35
decreased mean corpuscular hem... 34 | 34
female infertility 34 | 34
tremors 34 | 34
decreased circulating calcium ... 33 | 33
abnormal cranium morphology 32 | 32
decreased circulating chloride... 32 | 32
decreased threshold for audito... 32 | 32
increased circulating calcium ... 32 | 32
abnormal epididymis morphology 31 | 31
decreased T cell number 31 | 31
decreased blood urea nitrogen ... 31 | 31
decreased circulating fructosa... 31 | 31
increased circulating potassiu... 31 | 31

Disease

ovarian cancer 7 | 8,484
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
lung cancer 4 | 4,466
medulloblastoma, large-cell 4 | 6,234
osteosarcoma 4 | 7,933
atypical teratoid / rhabdoid tumor 3 | 4,369
glioblastoma 3 | 5,572
subependymal giant cell astrocytoma 3 | 2,287
tuberculosis 3 | 1,557
Carcinoma 2 | 2,147
active Crohn's disease 2 | 918
ependymoma 2 | 2,514
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
lung carcinoma 2 | 2,844
non-small cell lung cancer 2 | 2,798
pituitary cancer 2 | 1,972
psoriasis 2 | 6,685
sonic hedgehog group medulloblastoma 2 | 1,482
spina bifida 2 | 1,064
ulcerative colitis 2 | 2,087
Autistic Disorder 1 | 320
Batten disease 1 | 15
Blindness 1 | 84
Brain Diseases 1 | 22
Breast cancer 1 | 3,094
CORTICAL MALFORMATIONS, OCCIPITAL 1 | 1
Cancer 1 | 2,346
Child Development Disorders, Pervasive 1 | 55
Coffin-Lowry syndrome 1 | 10
DEAFNESS, AUTOSOMAL RECESSIVE 2 1 | 1
Deafness, Autosomal Dominant 11 1 | 1
Diabetes Mellitus, Non-Insulin-Dependent 1 | 157
Glaucoma 1 | 134
Gout 1 | 93
Heart disease 1 | 279
Hypertension 1 | 287
Hypokalemia 1 | 40
Idiopathic pulmonary fibrosis 1 | 21
Leber congenital amaurosis 1 | 72
Leprosy 1 | 77
Lung Diseases, Interstitial 1 | 15
Machado-Joseph disease 1 | 18
Melanoma 1 | 261
Menkes disease 1 | 20
Multiple myeloma 1 | 1,327
Nonsyndromic deafness 1 | 121
Primary cutaneous amyloidosis 1 | 26
Retinitis pigmentosa 1 | 153
Rheumatoid Arthritis 1 | 1,160
Root resorption 1 | 21
Sensorineural hearing loss 1 | 107
Stargardt disease 1 | 4
Trigeminal neuralgia 1 | 12
Type 2 diabetes mellitus 1 | 189
USHER SYNDROME, TYPE IB (disorder) 1 | 1
Usher Syndrome, Type I 1 | 1
Usher Syndrome, Type II 1 | 4
Usher syndrome 1 | 34
Usher syndrome type 2 1 | 4
Usher syndrome, type 1B 1 | 1
Wilson disease 1 | 16
X-linked cerebral adrenoleukodystrophy 1 | 115
adrenocortical carcinoma 1 | 1,427
adult high grade glioma 1 | 2,148
astrocytic glioma 1 | 2,241
astrocytoma 1 | 1,493
cutaneous lupus erythematosus 1 | 1,056
cystic fibrosis 1 | 1,665
diabetes mellitus 1 | 1,663
ductal carcinoma in situ 1 | 1,745
gastric carcinoma 1 | 832
group 3 medulloblastoma 1 | 2,254
interstitial cystitis 1 | 2,299
interstitial lung disease 1 | 291
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
invasive ductal carcinoma 1 | 2,950
limb girdle muscular dystrophy 2B 1 | 74
lung adenocarcinoma 1 | 2,713
malignant mesothelioma 1 | 3,162
medulloblastoma 1 | 1,524
nasopharyngeal carcinoma 1 | 1,056
posterior fossa group B ependymoma 1 | 1,530
primary pancreatic ductal adenocarcinoma 1 | 1,271
tuberculosis and treatment for 6 months 1 | 686

Tissue

Blood and immune system 11 | 17,995
Cardiovascular System 11 | 17,958
Digestive Tract 11 | 18,473
Endocrine System 11 | 18,512
Liver and Pancreas 11 | 18,136
Nervous System 11 | 18,561
Skin and soft tissues 11 | 18,115
Urinary Tract 11 | 18,444
Female tissues 10 | 18,647
Male tissues 10 | 17,969
Respiratory system 10 | 17,484

Target Family

Non-IDG 7 | 11,971
Enzyme 1 | 4,146
Kinase 1 | 634
Transcription Factor 1 | 1,400
Transporter 1 | 473

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Protein FAM160A1 FAM160A1 Tdark Non-IDG 0.00000 6
Laminin subunit gamma-3 LAMC3 Tbio Non-IDG -1.33798 20.6 68
Probable phospholipid-transporting ATPase IH ATP11A Tbio Transporter -3.15459 1155.2 42
ADP-dependent glucokinase ADPGK Tbio Kinase -0.75433 6.95 123
Methyl-CpG-binding domain protein 1 MBD1 Tbio Transcription Factor -2.19366 164.7 282
Unconventional myosin-VIIa MYO7A Tbio Non-IDG -2.12316 131.7 114
von Willebrand factor A domain-containing protein 8 VWA8 Tdark Non-IDG -0.17609 1.48 6
Josephin-1 JOSD1 Tdark Non-IDG -0.31686 2.06 38
GDP-mannose 4,6 dehydratase GMDS Tbio Enzyme -2.00846 105.0 102
Apolipoprotein C-IV APOC4 Tbio Non-IDG -0.84699 7.03 46